Tuberculous lymphadenitis | |
---|---|
Specialty | Infectious disease |
Peripheral tuberculous lymphadenitis (or tuberculous adenitis) is a form of tuberculosis infection occurring outside of the lungs.[1] In general, it describes tuberculosis infection of the lymph nodes, leading to lymphadenopathy. When cervical lymph nodes are affected, it is commonly referred to as "Scrofula."[2] A majority of tuberculosis infections affect the lungs, and extra-pulmonary tuberculosis infections account for the remainder; these most commonly involve the lymphatic system.[3] Although the cervical region is most commonly affected, tuberculous lymphadenitis can occur all around the body, including the axillary and inguinal regions.[4]
The characteristic morphological element is the tuberculous granuloma (caseating tubercule). This consists of giant multinucleated cells and (Langhans cells), surrounded by epithelioid cells aggregates, T cell lymphocytes and fibroblasts.[5] Granulomatous tubercules eventually develop central caseous necrosis and tend to become confluent, replacing the lymphoid tissue.
Epidemiology
The exact prevalence of tuberculous lymphadenitis varies between countries and regions, with higher rates seen in developing countries.[1][3][5] Studies have shown that women may have higher rates of tuberculous lymphadenitis compared to men.[1] Conversely, men appear to have higher rates of pulmonary tuberculosis.[1] In regions where tuberculosis is not endemic, many of those affected with tuberculous lymphadenitis are foreign-born. In general, tuberculous lymphadenitis is more frequently seen in immunocompromised patients, such as those with uncontrolled HIV.[1]
Causes
Mycobacterium tuberculosis is the most common cause of both pulmonary tuberculosis and tuberculous lymphadenitis.[1][6] Historically, transmission of Mycobacterium bovis from dairy consumption was another frequent cause of tuberculous lymphadenitis, but incidence has drastically decreased in developed countries since the advent of pasteurization and other efforts to prevent bovine tuberculosis.[1] Tuberculous lymphadenitis has sometimes been caused by other related bacteria, including M. kansasii, M. fortuitum, M. marinum, and Mycobacterium ulcerans.[5]
Signs and symptoms
Tuberculous lymphadenitis typically involves a gradual and usually painless swelling of the affected lymph nodes (termed lymphadenitis).[1] Duration of symptoms can vary, and ranges between weeks to months following initial onset.[1] Unilateral lymph node involvement accounts for the majority of cases, and involvement of the cervical lymph nodes is the most common.[1]
In addition to swollen lymph nodes, the person may experience mild fevers, decreased appetite, or weight loss.[5] Pulmonary tuberculosis infection may co-occur with tuberculous lymphadenitis and account for additional symptoms such as cough.[1]
Stages
Stages of tubercular lymphadenitis:
- Lymphadenitis
- Periadenitis
- Cold abscess
- 'Collar stud' abscess
- Sinus
Tuberculous lymphadenitis is popularly known as collar stud abscess, due to its proximity to the collar bone and its superficial resemblance to a collar stud, although this is just one of the five stages of the disease. One or more affected lymph nodes can also be in a different body part, although it is most typical to have at least one near the collar bone.[4] The characteristic morphological element is the tuberculous granuloma (caseating tubercule): giant multinucleated cells (Langhans cells), surrounded by epithelioid cells aggregates, T cell lymphocytes and few fibroblasts. Granulomatous tubercules evolve to central caseous necrosis and tend to become confluent, replacing the lymphoid tissue.
Diagnosis
The gold standard for diagnosis of tuberculous lymphadenitis is to obtain a culture, though results may take weeks. A positive acid-fast bacteria (AFB) stain can support the diagnosis.[1] Other possible methods include nucleic acid amplification tests, fine needle aspiration (FNA), or excisional biopsy, the most invasive method.[1]
Supplementary studies to aid in diagnosis include tuberculin skin tests, interferon-gamma release assays, or chest X-rays.[1]
Treatment
Treatment of tuberculous lymphadenitis involves an anti-tuberculosis medication regimen for at least 6 months. This includes isoniazid, rifampin, pyrazinamide, and ethambutol depending on susceptibility to the drug.[1]
While surgical removal of affected lymph nodes alongside antibiotic therapy has shown some efficacy, there are no formal recommendations for surgery to treat tuberculous lymphadenitis.[1]
References
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Fontanilla JM, Barnes A, von Reyn CF (September 2011). "Current diagnosis and management of peripheral tuberculous lymphadenitis". Clinical Infectious Diseases. 53 (6): 555–562. doi:10.1093/cid/cir454. PMID 21865192.
- ↑ Gopalaswamy R, Dusthackeer VA, Kannayan S, Subbian S (May 26, 2021). "Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance". Journal of Respiration. 1 (2): 141–164. doi:10.3390/jor1020015. ISSN 2673-527X.
- 1 2 Mekonnen D, Derbie A, Abeje A, Shumet A, Nibret E, Biadglegne F, et al. (2019-04-19). "Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysis". PLOS ONE. 14 (4): e0215647. Bibcode:2019PLoSO..1415647M. doi:10.1371/journal.pone.0215647. PMC 6474617. PMID 31002716.
- 1 2 Cockerham WC (2016-10-06). International Encyclopedia of Public Health. Academic Press. p. 274. ISBN 9780128037089.
- 1 2 3 4 Bhat SM (2016-06-30). SRB's Manual of Surgery. JP Medical Ltd. pp. 55–56. ISBN 9789351524168.
- ↑ Adigun R, Singh R (2023). "Tuberculosis". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 28722945. Retrieved 2024-01-06.